|
|
|
|
|
|
MBS8220034-15nmol
|
MyBiosource |
|
15nmol |
|
|
|
MBS8220034-30nmol
|
MyBiosource |
|
30nmol |
|
|
|
MBS8220034-5x30nmol
|
MyBiosource |
|
5x30nmol |
|
|
|
MBS8224676-15nmol
|
MyBiosource |
|
15nmol |
|
|
|
MBS8224676-30nmol
|
MyBiosource |
|
30nmol |
|
|
|
MBS8224676-5x30nmol
|
MyBiosource |
|
5x30nmol |
|
|
|
SR509207
|
Origene Technologies GmbH |
|
2 nmol |
|
|
|
SR413069
|
Origene Technologies GmbH |
|
2 nmol |
|
|
|
SR325250
|
Origene Technologies GmbH |
|
2 nmol |
|
|
|
CSB-CL874787HU
|
Cusabio |
|
10 μg plasmid + 200μl Glycerol |
|
|
|
MBS8562012-01mLAF405L
|
MyBiosource |
|
0.1mL(AF405L) |
|
|
|
MBS8562012-01mLAF405S
|
MyBiosource |
|
0.1mL(AF405S) |
|
|
|
MBS8562012-01mLAF610
|
MyBiosource |
|
0.1mL(AF610) |
|
|
|
MBS8562012-01mLAF635
|
MyBiosource |
|
0.1mL(AF635) |
|
|
|
MBS8562012-02mL
|
MyBiosource |
|
0.2mL |
|
|
|
|
|
C46544-100ul
|
Assay Biotech |
|
100μl |
|
|
|
C46544-50ul
|
Assay Biotech |
|
50μl |
|
|
|
RN209494
|
Origene Technologies GmbH |
|
10 µg |
|
|
|
MBS1267147-001mgPlasmid02mLGlycerolStock
|
MyBiosource |
|
0.01mgPlasmid+0.2mLGlycerol-Stock |
|
|
|
MBS1267147-5x001mgPlasmid5x02mLGlycerolStock
|
MyBiosource |
|
5x0.01mgPlasmid+5x0.2mLGlycerol-Stock |
|
|
|
CSB-CL874787HU-10ug
|
Cusabio |
|
10ug |
|
|
|
SC309769
|
Origene Technologies GmbH |
|
10 µg |
|
|
|
SC110675
|
Origene Technologies GmbH |
|
10 µg |
|
|
|
ABP60573-003ml
|
Abbkine |
|
0.03ml |
|
|
|
ABP60573-01ml
|
Abbkine |
|
0.1ml |
|
|
|
ABP60573-02ml
|
Abbkine |
|
0.2ml |
|
|
|
E11-201387
|
EnoGene |
|
100ug/100ul |
|
|
|
BT-AP14655-100ul
|
Jiaxing Korain Biotech Ltd (BT Labs) |
|
100ul |
|
|
|
BT-AP14655-20ul
|
Jiaxing Korain Biotech Ltd (BT Labs) |
|
20ul |
|
|
|
BT-AP14655-50ul
|
Jiaxing Korain Biotech Ltd (BT Labs) |
|
50ul |
|
|
|
|
|
MBS8530741-01mg
|
MyBiosource |
|
0.1mg |
|
|
|
MBS8530741-01mLAF405L
|
MyBiosource |
|
0.1mL(AF405L) |
|
|
|
MBS8530741-01mLAF405S
|
MyBiosource |
|
0.1mL(AF405S) |
|
|
|
MBS8530741-01mLAF610
|
MyBiosource |
|
0.1mL(AF610) |
|
|
|
MBS8530741-01mLAF635
|
MyBiosource |
|
0.1mL(AF635) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|